NDC 63187-530

Regular Strength Aspirin EC

Aspirin

Regular Strength Aspirin EC is a Oral Tablet, Delayed Release in the Human Otc Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Aspirin.

Product ID63187-530_7eb67426-706c-4d6e-b93b-1ffe200c58c0
NDC63187-530
Product TypeHuman Otc Drug
Proprietary NameRegular Strength Aspirin EC
Generic NameAspirin
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2011-09-09
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart343
Labeler NameProficient Rx LP
Substance NameASPIRIN
Active Ingredient Strength325 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63187-530-00

100 TABLET, DELAYED RELEASE in 1 BOTTLE (63187-530-00)
Marketing Start Date2018-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63187-530-00 [63187053000]

Regular Strength Aspirin EC TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-12-01

NDC 63187-530-60 [63187053060]

Regular Strength Aspirin EC TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-12-01

NDC 63187-530-72 [63187053072]

Regular Strength Aspirin EC TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-12-01

NDC 63187-530-30 [63187053030]

Regular Strength Aspirin EC TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-12-01

NDC 63187-530-90 [63187053090]

Regular Strength Aspirin EC TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-12-01

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN325 mg/1

OpenFDA Data

SPL SET ID:05a4814f-9bd8-48a6-a92b-626b006b7a0f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198467
    • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
    • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

    • NDC Crossover Matching brand name "Regular Strength Aspirin EC" or generic name "Aspirin"

    NDCBrand NameGeneric Name
    0615-0564Regular Strength Aspirin ECRegular Strength Aspirin EC
    71335-0568Regular Strength Aspirin ECRegular Strength Aspirin EC
    0904-2013Regular Strength Aspirin ECRegular Strength Aspirin EC
    0904-2011Regular Strength Aspirin ECRegular Strength Aspirin EC
    33261-153Regular Strength Aspirin ECRegular Strength Aspirin EC
    50090-3450Regular Strength Aspirin ECRegular Strength Aspirin EC
    52959-018Regular Strength Aspirin ECRegular Strength Aspirin EC
    55700-338Regular Strength Aspirin ECRegular Strength Aspirin EC
    63187-530Regular Strength Aspirin ECRegular Strength Aspirin EC
    67046-170Regular Strength Aspirin ECRegular Strength Aspirin EC
    67544-468Regular Strength Aspirin ECRegular Strength Aspirin EC
    0904-6784Regular Strength Aspirin ECRegular Strength Aspirin EC
    0363-0157AspirinAspirin
    0363-0218AspirinAspirin
    0363-0227AspirinAspirin
    0113-0773Basic Care AspirinAspirin
    0113-7467basic care aspirinAspirin
    0280-2100BayerAspirin
    0280-2110Bayer Aspirin RegimenAspirin
    0280-2080Bayer Aspirin Regimen ChewableAspirin
    0280-2090Bayer Chewable - Aspirin RegimenAspirin
    0280-2000Bayer Genuine AspirinAspirin
    0280-2040Bayer PlusAspirin
    0280-2200Bayer WomensAspirin
    0067-6424BUFFERINASPIRIN
    0113-0259good sense aspirinAspirin
    0113-0274Good Sense aspirinAspirin
    0113-0416good sense aspirinAspirin
    0113-0467good sense aspirinAspirin
    0113-1919Good Sense Aspirinaspirin
    0363-0183Regular Strength Tri-Buffered AspirinAspirin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.